TTOO Current Ratio vs Asset Turnover Analysis
TTOO Stock | USD 3.00 0.05 1.64% |
T2 Biosystms financial indicator trend analysis is much more than just breaking down T2 Biosystms prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether T2 Biosystms is a good investment. Please check the relationship between T2 Biosystms Current Ratio and its Asset Turnover accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
Current Ratio vs Asset Turnover
Current Ratio vs Asset Turnover Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of T2 Biosystms Current Ratio account and Asset Turnover. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between T2 Biosystms' Current Ratio and Asset Turnover is -0.51. Overlapping area represents the amount of variation of Current Ratio that can explain the historical movement of Asset Turnover in the same time period over historical financial statements of T2 Biosystms, assuming nothing else is changed. The correlation between historical values of T2 Biosystms' Current Ratio and Asset Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Ratio of T2 Biosystms are associated (or correlated) with its Asset Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Asset Turnover has no effect on the direction of Current Ratio i.e., T2 Biosystms' Current Ratio and Asset Turnover go up and down completely randomly.
Correlation Coefficient | -0.51 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Asset Turnover
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.Most indicators from T2 Biosystms' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.As of the 29th of March 2024, Selling General Administrative is likely to drop to about 26 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 45 M
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 6.6M | 6.1M | 5.7M | 5.0M | Depreciation And Amortization | 318K | 39K | 35.1K | 33.3K |
T2 Biosystms fundamental ratios Correlations
Click cells to compare fundamentals
T2 Biosystms Account Relationship Matchups
High Positive Relationship
High Negative Relationship
T2 Biosystms fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.5M | 79.1M | 60.5M | 34.4M | 39.5M | 62.0M | |
Short Long Term Debt Total | 44.8M | 55.8M | 57.1M | 59.2M | 68.1M | 40.9M | |
Other Current Liab | 13.6M | 6.4M | 7.2M | 7.7M | 8.8M | 6.6M | |
Total Current Liabilities | 60.6M | 9.8M | 11.7M | 10.5M | 12.1M | 23.0M | |
Total Stockholder Equity | (34.0M) | 8.7M | (12.9M) | (40.0M) | (46.0M) | (43.7M) | |
Other Liab | 46K | 4.8M | 4.6M | 4.9M | 5.6M | 5.9M | |
Property Plant And Equipment Net | 9.2M | 14.8M | 14.4M | 13.3M | 15.3M | 9.8M | |
Net Debt | 33.7M | 39.0M | 34.9M | 48.9M | 56.2M | 59.0M | |
Retained Earnings | (376.2M) | (423.0M) | (472.2M) | (534.5M) | (481.1M) | (457.0M) | |
Accounts Payable | 3.8M | 2.1M | 2.8M | 1.3M | 1.5M | 1.6M | |
Cash | 11.0M | 16.8M | 22.2M | 10.3M | 9.3M | 8.8M | |
Non Current Assets Total | 9.6M | 25.5M | 16.1M | 15.0M | 17.2M | 11.7M | |
Cash And Short Term Investments | 11.0M | 42.2M | 32.2M | 10.3M | 9.3M | 8.8M | |
Common Stock Total Equity | 36K | 44K | 51K | 147K | 169.1K | 177.5K | |
Common Stock Shares Outstanding | 455.1K | 24.3K | 31.8K | 51.0K | 58.7K | 55.7K | |
Liabilities And Stockholders Equity | 28.5M | 79.1M | 60.5M | 34.4M | 39.5M | 62.0M | |
Non Current Liabilities Total | 1.9M | 60.6M | 61.8M | 63.9M | 57.5M | 34.1M | |
Other Current Assets | 1.4M | 2.7M | 3.1M | 2.6M | 3.0M | 1.5M | |
Other Stockholder Equity | 342.1M | 431.5M | 459.2M | 494.6M | 568.7M | 288.0M | |
Total Liab | 62.5M | 70.4M | 73.4M | 74.4M | 66.9M | 50.8M | |
Property Plant And Equipment Gross | 9.2M | 14.8M | 14.4M | 13.3M | 15.3M | 9.8M | |
Total Current Assets | 18.9M | 53.6M | 44.4M | 19.4M | 17.5M | 16.6M | |
Accumulated Other Comprehensive Income | (11.3M) | (13.2M) | 9K | (4K) | (3.6K) | (3.8K) | |
Short Term Debt | 42.9M | 1.2M | 1.2M | 1.4M | 1.6M | 1.5M | |
Common Stock | 49K | 147K | 166K | 8K | 9.2K | 8.7K | |
Property Plant Equipment | 5.8M | 14.8M | 14.4M | 13.3M | 15.3M | 9.5M | |
Net Tangible Assets | (32.1M) | 8.7M | (12.9M) | (40.0M) | (36.0M) | (34.2M) | |
Current Deferred Revenue | 285K | 230K | 518K | 172K | 154.8K | 147.1K | |
Net Receivables | 2.8M | 5.1M | 5.1M | 2.2M | 2.5M | 2.2M | |
Retained Earnings Total Equity | (266.1M) | (317.2M) | (376.2M) | (423.0M) | (380.7M) | (399.7M) | |
Capital Surpluse | 267.4M | 328.5M | 342.1M | 431.5M | 496.3M | 308.8M | |
Inventory | 3.6M | 3.6M | 3.9M | 4.3M | 5.0M | 2.6M | |
Capital Lease Obligations | 3.9M | 10.5M | 9.4M | 9.6M | 11.0M | 5.7M |
Currently Active Assets on Macroaxis
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.62) | Revenue Per Share 7.933 | Quarterly Revenue Growth (0.60) | Return On Assets (0.68) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.